Loading
Latest filing published 30 Aug 2018 for Zomedica Pharmaceuticals Corp., €368k.
James LeBar appears in our data through filings on Zomedica Pharmaceuticals Corp. shares, published by SEDI. Between 24 January 2018 and 28 August 2018, the trades on record add up to 2 filings.
No open-market purchase appears, only 1 sale worth €368k. Outside the open market, there are 1 option exercise.
Most recently, on 30 August 2018, the filings show an open-market sale worth €368k in Zomedica Pharmaceuticals Corp. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations